Recent studies have reported that FOXP3+ T-cell infiltration is associated with poor clinical outcome [17]-[22], whereas others found no significant prognostic role for FOXP3+ infiltration in a large series of breast cancers [23]. The gene discussed is FOXP3; the disease is breast cancer.